DMAA · Company research
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 10.84 | $349,986,019.6 | 349965739.60 | 94.65845853090695080548 | — | — | — | 2.5404233215502099 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.